News

Beckman’s clinical diagnostics revenues increased 21.5% in constant currency in the second quarter, due to Olympus and growth in Asia Pacific. The company has also posted operating income

Genticel is expected to conduct the clinical trial in Belgium starting Q3 2010. ProCervix is composed of two recombinant Adenylate Cyclase proteins (CyaA) in equal parts. One protein

Sensient has posted a net income of $ 28,685 for the second quarter 2010, or $0.58 per diluted share, compared to $25,819, or $0.53per diluted share, for the

Illumina claimed that the kit, which the company has commenced shipping broadly, is the first in a series of new kits that further advance data quality, ease of

With these launches the company plans to expand its product selection in order to offer a more comprehensive range of amino acids. Amino’s current line-up of amino acids

Takepron is a proton pump inhibitor discovered by Takeda Pharmaceutical and has been launched since 1992 in Japan. Takeda Pharmaceutical said that administration of low-dose aspirin for a

XOMA and AVEO said that the milestone payment resulted from AVEO’s recent commencement of AV-299 Phase 2 clinical trial to evaluate its antibody for the treatment of non-small

Cepheid has posted a net loss of $1.8m or $(0.03) per diluted share, for the second quarter of 2010, when compared to revenues of $41.0m and a net

As per the terms of the agreement NovImmune is expected to get an upfront payment and is eligible to receive clinical milestones and royalties on sales. NovImmune said